Health ❯ Vaccines ❯ mRNA Technology ❯ Public Health

Vaccine Development

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Citing failure of mRNA vaccines against upper respiratory infections, he redirected resources toward broader vaccine platforms beyond mRNA.

U.S. Cancels Moderna’s $600 Million Bird Flu Vaccine Contract